Fuda Cancer Hospital
Fuda Cancer Hospital
China, Cantão
| China | Turki | Austria | |
| Tomoterapi | dari $17,500 | dari $12,000 | dari $30,000 |
| Terapi radiasi untuk kanker usus | dari $10,500 | dari $5,800 | dari $6,864 |
| Terapi Intravena Kurkumin | dari $350 | dari $350 | dari $350 |
| Sistem Robotik Da Vinci | dari $24,500 | dari $9,500 | dari $22,000 |
| Pengangkatan polip lambung | dari $1,800 | dari $990 | dari $5,000 |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Tingkat kelangsungan hidup relatif lima tahun untuk kanker usus besar di Tiongkok berkisar antara sekitar 58% hingga 62%. Diagnosis dini memastikan tingkat kelangsungan hidup yang tinggi—85% hingga 96%. Hasil pengobatan sangat berkorelasi dengan lokasi geografis dan penggunaan pembedahan radikal dibandingkan perawatan paliatif.
Opini ahli Bookimed: Di Tiongkok, volume pasien adalah indikator terpenting kualitas perawatan medis. Rumah Sakit Kanker Fuda melayani lebih dari 30.000 pasien internasional. Rumah Sakit Kemanusiaan Xiamen merawat sekitar 1.000.000 pasien setiap tahunnya. Pusat-pusat dengan volume pasien tinggi seringkali menyediakan akses lebih cepat ke teknologi khusus, seperti NanoKnife dan CyberKnife M6, untuk kasus-kasus kompleks.
Opini pasien: Pasien menekankan pentingnya memilih rumah sakit tersier di kota-kota besar untuk memastikan hasil yang memenuhi standar Barat. Banyak yang merekomendasikan penggunaan aplikasi khusus untuk pelacakan statistik secara real-time dan manajemen perawatan pascaoperasi.
Di Tiongkok, pengobatan kanker usus besar berfokus pada reseksi bedah dan teknik invasif minimal. Di rumah sakit, laparoskopi digunakan dalam lebih dari 56% kasus untuk memastikan pemulihan yang lebih cepat. Di pusat-pusat canggih, pembedahan khusus dikombinasikan dengan kemoterapi, terapi target, atau imunoterapi berdasarkan penanda genetik seperti status KRAS dan MSI.
Opini ahli Bookimed: Meskipun sebagian besar pusat mengikuti protokol standar, Rumah Sakit Kanker Fuda menonjol dengan menggunakan lebih dari 10 jenis perawatan invasif minimal. Spesialisasi mereka dalam krioterapi dan terapi vaskular intervensi memberikan alternatif bagi pasien yang tidak dapat mentolerir kemoterapi agresif (lebih dari 30.000 kasus di seluruh dunia).
Perspektif pasien: Pasien mencatat bahwa meskipun pembedahan adalah pengobatan lini pertama standar, akses ke diagnostik canggih seperti pengujian PD-L1 seringkali bergantung pada apakah Anda tinggal di kota besar.
Di Tiongkok, kanker usus besar stadium 4 dapat diobati menggunakan protokol multidisiplin canggih di pusat kanker khusus. Lembaga medis menggunakan reseksi radikal, ablasi nanoknife, dan kemoterapi intraperitoneal hipertermik untuk mengobati penyakit metastasis. Integrasi terapi obat modern dengan perawatan suportif tradisional membantu memperpanjang kelangsungan hidup dan menjaga kualitas hidup pasien.
Opini ahli Bookimed: Pasien yang mencari pengobatan di Tiongkok sebaiknya memprioritaskan fasilitas medis terakreditasi JCI di pusat-pusat besar seperti Guangzhou. Data menunjukkan bahwa klinik seperti Rumah Sakit Kanker Fuda mengkhususkan diri dalam perawatan invasif minimal seperti krioterapi dan NanoKnife. Pilihan ini berfungsi sebagai alternatif bagi mereka yang tidak toleran terhadap kemoterapi dosis tinggi standar.
Opini pasien: Pasien mencatat bahwa untuk diagnosis akurat mengenai stadium penyakit, pemeriksaan pencitraan di rumah sakit kota besar dan terkemuka sangat penting. Banyak yang menekankan bahwa, meskipun biaya terapi multimodal cukup signifikan, tingkat kualifikasi spesialis di pusat-pusat akademik terkemuka sebanding dengan standar Barat.
Pengobatan tradisional Tiongkok (TCM) digunakan di Tiongkok sebagai terapi integratif komplementer untuk kanker usus besar. TCM menggabungkan pengobatan herbal, akupunktur, dan modifikasi gaya hidup dengan pembedahan atau kemoterapi untuk meningkatkan kualitas hidup. Protokol ini bertujuan untuk mengurangi efek samping pengobatan dan memperkuat respons imun.
Pendapat ahli Bookimed: Pengobatan integratif di Tiongkok sering menggabungkan praktik kuno dengan teknologi mutakhir dalam satu fasilitas medis. Misalnya, Rumah Sakit Jinshazhou dari Universitas Pengobatan Tradisional Tiongkok Guangzhou menawarkan radioterapi CyberKnife M6 bersamaan dengan protokol tradisional. Data kami menunjukkan bahwa pusat-pusat khusus ini menawarkan paket komprehensif dengan biaya sekitar $7.900, termasuk konsultasi medis dan rawat inap.
Umpan balik pasien: Pasien mencatat bahwa infus herbal intravena dan akupunktur sering diberikan langsung di kamar rumah sakit. Mereka menekankan pentingnya menggunakan perawatan ini untuk meredakan nyeri dan mempercepat penyembuhan luka setelah reseksi usus besar.
Tiongkok menawarkan perawatan khusus untuk tumor yang tidak dapat dioperasi, termasuk krioterapi, nanoknife, dan imunoterapi canggih. Institusi seperti Rumah Sakit Kanker Fuda diakreditasi oleh Joint Commission International (JCI). Mereka mengkhususkan diri dalam pengobatan kanker stadium lanjut, menggunakan lebih dari 10 jenis perawatan minimal invasif untuk menangani kasus-kasus kompleks.
Opini ahli Bookimed: Sementara banyak negara berfokus pada monoterapi untuk penyakit stadium lanjut, pusat-pusat khusus di Tiongkok sering menggabungkan krioterapi dengan intervensi vaskular. Rumah Sakit Kanker Fuda telah menggunakan pendekatan gabungan ini untuk merawat lebih dari 30.000 pasien dari 100 negara. Volume kasus internasional yang besar ini menunjukkan adanya infrastruktur yang maju untuk mengelola protokol pengobatan multi-tahap yang kompleks, yang mungkin tidak tersedia di tempat lain.
Opini Pasien: Pasien dengan tumor stadium lanjut mencatat bahwa meskipun perawatan seperti CyberKnife dapat mengecilkan lesi yang tidak dapat dioperasi, perawatan tersebut membutuhkan pengerahan fisik yang signifikan dan menyebabkan kelelahan. Banyak yang menekankan pentingnya meninjau data uji klinis sebelum memulai perawatan imunoterapi baru karena variabilitas hasil klinis.
Top Chinese hospitals offer colon cancer care equivalent to Western standards through JCI-accredited facilities. Centres in Guangzhou and Beijing provide five-year survival rates around 62.6%. They use tools like the Da Vinci Robotic System and NanoKnife for precise tumour removal.
Bookimed Expert Insight: China's private cancer centres often provide faster access to emerging therapies than public Western systems. For example, Xiamen Humanity Hospital houses a Boron Neutron Capture Therapy (BNCT) centre and conducts Phase I–IV trials. This makes China a viable destination for patients seeking robotic-assisted surgeries. It also offers stereotactic treatments like CyberKnife M6, which may cost approximately A$11,200.
Patient Consensus: Patients find that China’s top urban hospitals match Western technical capabilities. These facilities often provide faster treatment starts. Patients recommend confirming if a multidisciplinary tumour board oversees the case to help coordinate care after surgery.
Top Chinese hospitals report a 5-year survival rate of 82% in major cities. Specialised centres often exceed the national average of 62%. Success relies on early detection. Stage I survival reaches 96% in these cases. Leading facilities use robotic surgery and precision radiotherapy to improve outcomes.
Bookimed Expert Insight: High-volume centres like Xiamen Humanity Hospital treat 1,000,000 patients yearly. This massive volume allows surgeons to specialise in niche techniques. For example, Dr Liu Shi Xin at Xiamen focuses on precision VMAT and SBRT for abdominal malignancies. High repetition rates often lead to better technical precision during complex colon resections.
Patient Consensus: Patients value finding a surgeon with high case volumes over hospital brands. They note that multidisciplinary teams in China help coordinate surgery, chemotherapy, and follow-up care.
China offers colon cancer treatments like NanoKnife, Boron Neutron Capture Therapy (BNCT), and integrative Traditional Chinese Medicine (TCM). Specialists combine minimally invasive procedures with targeted therapies and immunotherapy to treat late-stage cases. JCI-accredited hospitals in Guangzhou and Xiamen provide these alternatives to standard chemotherapy.
Bookimed Expert Insight: Patients seeking experimental options can access clinical trials at research centres like Xiamen Humanity Hospital. While many clinics offer Da Vinci surgery, Fuda Cancer Hospital specialises in over 10 types of minimally invasive therapies. These are designed to replace or supplement intensive chemotherapy for advanced-stage patients.
China integrates Traditional Chinese Medicine (TCM) as an adjunct to surgery and chemotherapy for colon cancer. This dual-track approach manages side effects and supports recovery within JCI-accredited facilities. Specialised hospitals use TCM formulas to restore gut function and boost immunity after major bowel resections.
Bookimed Expert Insight: Bookimed data shows several top-tier Chinese cancer centres sit within Universities of Chinese Medicine. For example, Jinshazhou Hospital is part of Guangzhou University of Chinese Medicine. This proximity allows for seamless coordination between radiation oncologists and TCM experts. Dr Liu Shi Xin and his team can manage herbal support alongside precision radiotherapy. Australian patients benefit from this structure because one clinical team manages both treatments.
Patient Consensus: Patients find Chinese hospitals often provide coordinated care between oncology and TCM departments. They note that herbal therapies help with maintaining appetite and energy during intensive chemotherapy.
International patients can access colon cancer clinical trials and experimental treatments in China. Specialised research centres like Xiamen Humanity Hospital conduct Phase I–IV trials. Facilities often provide technologies like NanoKnife or Boron Neutron Capture Therapy (BNCT). Patients must meet strict inclusion criteria and provide detailed medical records.
Bookimed Expert Insight: Xiamen Humanity Hospital serves 1,000,000 patients annually and houses China's first BNCT centre. This high volume and specialised infrastructure often allow for earlier access to experimental protocols. Australian patients should note that some packages, like CyberKnife at Jinshazhou Hospital, focus on the procedure only.
Patient Consensus: Patients note it is essential to have pathology and molecular results ready in English. Many find that logistical coordination and confirming trial eligibility for non-Chinese nationals are vital steps before travelling.
Hospitals in China such as Fuda Cancer Hospital and Xiamen Humanity Hospital are recognised for international colon cancer care. These JCI-accredited facilities specialise in minimally invasive therapies and robotic surgery. Centres in Guangzhou and Xiamen treat thousands of international patients annually using precision medicine.
Bookimed Expert Insight: While many patients focus on surgery, China's oncology landscape offers unique non-surgical alternatives. Fuda Cancer Hospital provides over 10 types of minimally invasive therapies. This focus on alternatives to traditional chemotherapy makes it a hub for patients from over 100 countries seeking gentler treatment options.
International patients receive coordination support through dedicated hospital departments in China. This includes visa assistance, clinic transfers, and medical record translation. Clinics like Fuda Cancer Hospital provide professional medical interpreters. These services help patients navigate consultations, diagnostics, and treatments like CyberKnife or robotic surgery.
Bookimed Expert Insight: Xiamen Humanity Hospital and Fuda Cancer Hospital serve thousands of internationals from 100+ countries. This high volume means their staff are accustomed to managing foreign medical histories. Patients should prioritise clinics with JCI accreditation for administrative and safety standards that match Australian expectations.
Patient Consensus: Patients note that international offices provide great initial support. However, having a private interpreter helps with pharmacy staff and everyday ward needs. They also recommend translating pathology reports before arriving in China to speed up registration.